Department of Radiology, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA.
Am J Physiol Heart Circ Physiol. 2012 Jul;303(1):H126-32. doi: 10.1152/ajpheart.00560.2011. Epub 2012 May 4.
Right heart catheterization is often required to monitor intra-cardiac pressures in a number of disease states. Ultrasound contrast agents can produce pressure modulated subharmonic emissions that may be used to estimate right ventricular (RV) pressures. A technique based on subharmonic acoustic emissions from ultrasound contrast agents to track RV pressures noninvasively has been developed and its clinical potential evaluated. The subharmonic signals were obtained from the aorta, RV, and right atrium (RA) of five anesthetized closed-chest mongrel dogs using a SonixRP ultrasound scanner and PA4-2 phased array. Simultaneous pressure measurements were obtained using a 5-French solid state micromanometer tipped catheter. Initially, aortic subharmonic signals and systemic blood pressures were used to obtain a calibration factor in units of millimeters of mercury per decibel. This factor was combined with RA pressures (that can be obtained noninvasively) and the acoustic data from the RV to obtain RV pressure values. The individual calibration factors ranged from -2.0 to -4.0 mmHg/dB. The subharmonic signals tracked transient changes in the RV pressures within an error of 0.6 mmHg. Relative to the catheter pressures, the mean errors in estimating RV peak systolic and minimum diastolic pressures, and RV relaxation [isovolumic negative derivative of change in pressure over time (-dP/dt)] by use of the subharmonic signals, were -2.3 mmHg, -0.8 mmHg, and 2.9 mmHg/s, respectively. Overall, acoustic estimates of RV peak systolic and minimum diastolic pressures and RV relaxation were within 3.4 mmHg, 1.8 mmHg, and 5.9 mmHg/s, respectively, of the measured pressures. This pilot study demonstrates that subharmonic emissions from ultrasound contrast agents have the potential to noninvasively track in vivo RV pressures with errors below 3.5 mmHg.
右心导管术常用于监测多种疾病状态下的心脏内压力。超声对比剂可产生压力调制的次谐波发射,可用于估计右心室(RV)压力。已经开发出一种基于超声对比剂次谐波声发射来无创性跟踪 RV 压力的技术,并评估了其临床潜力。使用 SonixRP 超声扫描仪和 PA4-2 相控阵从五只麻醉的闭胸杂种犬的主动脉、RV 和右心房(RA)获得次谐波信号。使用 5-French 固态微压力计尖端导管同时获得压力测量值。最初,使用主动脉次谐波信号和全身血压获得以毫米汞柱/分贝为单位的校准因子。该因子与 RA 压力(可无创获得)和 RV 的声学数据结合使用,以获得 RV 压力值。个别校准因子范围为-2.0 至-4.0 mmHg/dB。次谐波信号在 RV 压力的瞬态变化内跟踪误差为 0.6mmHg。与导管压力相比,使用次谐波信号估计 RV 收缩压峰值和最小舒张末期压力以及 RV 松弛[压力随时间变化的等容负导数(-dP/dt)]的平均误差分别为-2.3mmHg、-0.8mmHg 和 2.9mmHg/s。总体而言,RV 收缩压峰值和最小舒张末期压力以及 RV 松弛的声学估计值与测量压力的偏差分别在 3.4mmHg、1.8mmHg 和 5.9mmHg/s 以内。这项初步研究表明,超声对比剂的次谐波发射有可能以低于 3.5mmHg 的误差无创性跟踪体内 RV 压力。